Trial intelligence / Profile preview

Guiyuan Tablet for Protracted Opioid Withdrawal Symptoms

CTR20131291Phase 2Completed

Sponsor
Yabao Pharmaceutical Group Co., Ltd.
Start
Apr 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Guiyuan Tablet in opioid withdrawal, sponsored by Yabao Pharmaceutical Group Co., Ltd.. Started Apr 2015; status: completed.

02

Drugs

Guiyuan Tablet
03

Conditions

opioid withdrawal

Beyond the preview

Go deeper on CTR20131291.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20131291.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call